- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02061501
Evaluation of the Efficacy of Optometric Rehabilitation on Visual Cognitive Deficits in Children
Visual cognitive deficits in children are frequent, with an impact on working and daily activities. Optometric therapy may improve those functions, however few studies have been performed.
We aim to evaluate the efficacy of such therapy by a comparative study between two groups of children aged between 5 and 12 after 6 months of rehabilitation.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Strasbourg, France, 67098
- Recruiting
- CRTLA - Hôpital de Hautepierre- CHRU Strasbourg
-
Contact:
- Anne de Saint-Martin, MD
- Phone Number: +33 03 88 12 83 28
- Email: anne.desaintmartin@chru-strasbourg.fr
-
Principal Investigator:
- Anne de Saint-Martin, MD
-
Sub-Investigator:
- Claire de Sèze, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- visual cognitive deficits
- normal intelligence
Exclusion Criteria:
- cerebral palsy
- mental deficiency
- visual acuity deficit
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Speech therapy
Speech therapy (30 min per week) alone for the 6 first months.
Then speech therapy (30 min per week) and optometric therapy (30 min per week) for the 6 last months.
|
Optometric therapy during 6 months, once a week
|
|
Experimental: Speech therapy and optometric therapy
Speech therapy (30 min per week) and optometric therapy (30 min per week) for 12 months.
|
Optometric therapy once a week, during 12 months
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Calculation of a composite score at Visit 1
Time Frame: Visit 1 (6 months of rehabilitation)
|
The composite score is calculated from the results obtained at several neuropsychology and optometric tests. Basal score is calculated at Visit 0 (inclusion visit). |
Visit 1 (6 months of rehabilitation)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Calculation of a composite score at Visit 2
Time Frame: Visit 2 (12 months of rehabilitation)
|
The composite score is calculated from the results obtained at several neuropsychology and optometric tests.
|
Visit 2 (12 months of rehabilitation)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of life
Time Frame: Visit 2 (12 months of rehabilitation)
|
Quality of life assessed by a questionnaire at V0, V1 and V2.
|
Visit 2 (12 months of rehabilitation)
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 5542
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.